|
| Visit 2 (2) | Visit 3 (3) | End of study (4) | p value (Overall) |
| Disappearance of manifestations |
|
|
| <0.001c |
| None | 1 (1.8%)3,4 | 02 | 1 (1.8%)2 |
|
| Slight | 6 (10.7%) | 4 (7.1%) | 4 (7.1%) |
|
| Moderate | 31 (55.4%) | 5 (8.9%) | 16 (28.6%) |
|
| Great | 18 (32.1%) | 47 (83.9%) | 35 (62.5%) |
|
| Skin quality improvement |
|
|
| <0.001c |
| None | 03,4 | 02 | 02 |
|
| Slight | 4 (7.1%) | 0 | 2 (3.6%) |
|
| Moderate | 31 (55.4%) | 8 (14.3%) | 14 (25%) |
|
| Great | 21 (37.5%) | 48 (85.7%) | 40 (71.4%) |
|
| Assessment of total improvement |
|
|
| <0.001c |
| None | 03,4 | 02 | 1 (1.8%)2 |
|
| Slight | 3 (5.4%) | 3 (5.4%) | 2 (3.6%) |
|
| Moderate | 33 (58.9%) | 6 (10.7%) | 14 (25%) |
|
| Great | 20 (35.7%) | 47 (83.9%) | 39 (69.6%) |
|